BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 14556237)

  • 21. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV; Kuczenski R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland is associated with an inhibitory guanyl nucleotide component.
    Cote TE; Frey EA; Grewe CW; Kebabian JW
    J Neural Transm Suppl; 1983; 18():139-47. PubMed ID: 6308147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
    Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
    Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sites of action of ethanol on adenylate cyclase.
    Rabin RA; Molinoff PB
    J Pharmacol Exp Ther; 1983 Dec; 227(3):551-6. PubMed ID: 6606704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.
    Watts VJ; Lawler CP; Gonzales AJ; Zhou QY; Civelli O; Nichols DE; Mailman RB
    Synapse; 1995 Oct; 21(2):177-87. PubMed ID: 8584979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization?
    Slotkin TA; Lau C; McCook EC; Lappi SE; Seidler FJ
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):64-75. PubMed ID: 8048055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C; Abraini JH; David HN
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells.
    Black LE; Smyk-Randall EM; Sibley DR
    Mol Cell Neurosci; 1994 Dec; 5(6):567-75. PubMed ID: 7704430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexual experience alters D1 receptor-mediated cyclic AMP production in the nucleus accumbens of female Syrian hamsters.
    Bradley KC; Mullins AJ; Meisel RL; Watts VJ
    Synapse; 2004 Jul; 53(1):20-7. PubMed ID: 15150737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides.
    Verghese MW; Snyderman R
    J Immunol; 1983 Feb; 130(2):869-73. PubMed ID: 6294180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).
    Adlersberg M; Hsiung SC; Glickstein SB; Liu KP; Tamir H; Schmauss C
    J Neurochem; 2004 Aug; 90(4):865-73. PubMed ID: 15287892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic food restriction increases D-1 dopamine receptor agonist-induced phosphorylation of extracellular signal-regulated kinase 1/2 and cyclic AMP response element-binding protein in caudate-putamen and nucleus accumbens.
    Haberny SL; Berman Y; Meller E; Carr KD
    Neuroscience; 2004; 125(1):289-98. PubMed ID: 15051167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of dopamine1- and dopamine2-receptor agonists on the cAMP generating system in canine coronary and renal arteries.
    Wang WZ; Zhao RR; Qin FZ
    Methods Find Exp Clin Pharmacol; 1994 Dec; 16(10):691-6. PubMed ID: 7723468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine receptors in canine caudate nucleus.
    Maeno H
    Mol Cell Biochem; 1982 Mar; 43(2):65-80. PubMed ID: 6123940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation.
    Shin Y; White BH; Uh M; Sidhu A
    Brain Res; 2003 Apr; 968(1):102-13. PubMed ID: 12644268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of multiple dopamine signal transduction molecules by retinoids in the developing striatum.
    Wang HF; Liu FC
    Neuroscience; 2005; 134(1):97-105. PubMed ID: 15939542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological maturation and beta-adrenergic effectors: pre- and postnatal development of the adenylate cyclase system in the rabbit heart.
    Schumacher WA; Sheppard JR; Mirkin BL
    J Pharmacol Exp Ther; 1982 Dec; 223(3):587-93. PubMed ID: 6292391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats.
    Taymans JM; Kia HK; Groenewegen HJ; Leysen JE; Langlois X
    Neuroscience; 2005; 134(2):643-56. PubMed ID: 15964700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.